Anti-RPRM monoclonal antibody

Pre-made anti-RPRM monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RPRM/RPRM products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1552-Ab-1/ GM-Tg-hg-IP1552-Ab-2Anti-Human RPRM monoclonal antibodyHuman
GM-Tg-rg-IP1552-Ab-1/ GM-Tg-rg-IP1552-Ab-2Anti-Rat RPRM monoclonal antibodyRat
GM-Tg-mg-IP1552-Ab-1/ GM-Tg-mg-IP1552-Ab-2Anti-Mouse RPRM monoclonal antibodyMouse
GM-Tg-cynog-IP1552-Ab-1/ GM-Tg-cynog-IP1552-Ab-2Anti-Cynomolgus/ Rhesus macaque RPRM monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1552-Ab-1/ GM-Tg-felg-IP1552-Ab-2Anti-Feline RPRM monoclonal antibodyFeline
GM-Tg-cang-IP1552-Ab-1/ GM-Tg-cang-IP1552-Ab-2Anti-Canine RPRM monoclonal antibodyCanine
GM-Tg-bovg-IP1552-Ab-1/ GM-Tg-bovg-IP1552-Ab-2Anti-Bovine RPRM monoclonal antibodyBovine
GM-Tg-equg-IP1552-Ab-1/ GM-Tg-equg-IP1552-Ab-2Anti-Equine RPRM monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1552-Ab-1/ GM-Tg-hg-IP1552-Ab-2; GM-Tg-rg-IP1552-Ab-1/ GM-Tg-rg-IP1552-Ab-2;
GM-Tg-mg-IP1552-Ab-1/ GM-Tg-mg-IP1552-Ab-2; GM-Tg-cynog-IP1552-Ab-1/ GM-Tg-cynog-IP1552-Ab-2;
GM-Tg-felg-IP1552-Ab-1/ GM-Tg-felg-IP1552-Ab-2; GM-Tg-cang-IP1552-Ab-1/ GM-Tg-cang-IP1552-Ab-2;
GM-Tg-bovg-IP1552-Ab-1/ GM-Tg-bovg-IP1552-Ab-2; GM-Tg-equg-IP1552-Ab-1/ GM-Tg-equg-IP1552-Ab-2
Products NameAnti-RPRM monoclonal antibody
Formatmab
Target NameRPRM
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RPRM monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1552-Ag-1Recombinant multi-species RPRM/ REPRIMO protein
    ORF Viral VectorpGMLP000221human RPRM Lentivirus plasmid
    ORF Viral VectorvGMLP000221human RPRM Lentivirus particle
    ORF Viral VectorpGMLPm001213mouse Rprm Lentivirus plasmid
    ORF Viral VectorvGMLPm001213mouse Rprm Lentivirus particle


    Target information

    Target IDGM-IP1552
    Target NameRPRM
    Gene ID56475,67874,680110,696097,119867787,101087679,614739,100058360
    Gene Symbol and Synonyms2410012A13Rik,REPRIMO,RPRM
    Uniprot AccessionQ9NS64,Q5BJN9,Q1RMT2
    Uniprot Entry NameRPRM_HUMAN,RPRM_RAT,RPRM_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000177519
    Target ClassificationN/A

    The target: RPRM, gene name: RPRM, also named as REPRIMO. Predicted to be involved in regulation of mitotic cell cycle. Predicted to act upstream of or within regulation of cell cycle. Predicted to be integral component of membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.